Serum amyloid a protein: Not a relevant marker for recognition of cardiac allograft rejection [3]

Transplantation

Volumn 78, Issue 6, 2004, Pages 950-951

  Vermes, Emmanuelle ^a   Kirsch, Matthias ^a   Farrokhi, Titi ^a   Loisance, Daniel ^a   Fanen, Pascale ^a   Zimmermann, Régine ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; BIOLOGICAL MARKER; METHYLPREDNISOLONE;

BACTERIAL INFECTION; BACTERIUM; FUNGUS; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MAJOR CLINICAL STUDY; MYCOSIS; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; VIRUS; VIRUS INFECTION;

BIOLOGICAL MARKERS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; SERUM AMYLOID A PROTEIN;

EID: 4644298777     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000131817.91132.7E     Document Type: Letter

References (4)

1. Hartmann A, Eide TC, Fauchald P, et al. Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection. Nephrol Dial Transplant 1997; 12: 161.
2. Feussner G, Stech C, Dobmeyer J, et al. Serum amyloid A protein (SAA): a marker for liver allograft rejection in humans. Clin Investig 1994; 72: 1007.
3. Müller TF, Vogl M, Neumann MC, et al. Non-invasive monitoring using serum amyloid A and serum neopterin in cardiac transplantation. Clinica Chimica Acta 1998; 276: 63.
4. Billingham ME, Gary NRB, Hammond ME, at al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Lung Transplant 1990; 9: 587.